Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

BBD reports analyze effectiveness and safety of statin use

BBD reports analyze effectiveness and safety of statin use

Vitae earns $14M milestone payment from Boehringer Ingelheim

Vitae earns $14M milestone payment from Boehringer Ingelheim

Rosiglitazone therapy associated with increased risk for heart attack: Study

Rosiglitazone therapy associated with increased risk for heart attack: Study

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

Serotonin promotes beta cell expansion during pregnancy, offers possible cure for type 1 diabetes

Serotonin promotes beta cell expansion during pregnancy, offers possible cure for type 1 diabetes

Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

Dapagliflozin in addition to insulin improves glycemic control in type 2 diabetics

Dapagliflozin in addition to insulin improves glycemic control in type 2 diabetics

Family members who undergo gastric bypass surgery together experience better clinical outcomes

Family members who undergo gastric bypass surgery together experience better clinical outcomes

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

Artificial pancreas holds promise for treating Type 1 diabetes

Artificial pancreas holds promise for treating Type 1 diabetes

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Astellas presents ASP1941 selective SGLT2 inhibitor Phase 2 study results at 70th ADA

Astellas presents ASP1941 selective SGLT2 inhibitor Phase 2 study results at 70th ADA

AFREZZA provides long-term glucose control in Type 2 diabetics: Study

AFREZZA provides long-term glucose control in Type 2 diabetics: Study

High-phenolic-content olive oil modifies genes that promote inflammation

High-phenolic-content olive oil modifies genes that promote inflammation

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Clinical study results show no increased risk of CV events associated with SYMLIN injection

Clinical study results show no increased risk of CV events associated with SYMLIN injection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.